Sunday 18 October 2026 Export IGC’s income statement to Excel — free account

IGC Pharma, Inc.

IGC Pharma, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $1.3 million, down 5.50% from fiscal 2024. In the quarter to June 2026, revenue fell 19.7%, EPS fell 100.0%, free cash flow fell 103.3% and total debt rose 713.5%, each against the same quarter a year earlier. Operating cash flow growth for five consecutive years.

0.25 0.00 0.00%

Follow IGC

Alert me

Market cap: $26.3M
P/E: 0.0×
Fwd P/E: −3.6×
Dividend yield: —
F-score: 3/9
Altman Z: −16.58
Beneish M: −3.69
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	1	1	—	3	+8 more TTM periods Free account
ROE Full definition →	(143.46%)	(112.76%)	0.00%	(83.35%)
ROA Full definition →	(100.44%)	(78.30%)	0.00%	(64.11%)
ROIC Full definition →	(91.53%)	(79.70%)	0.00%	(52.51%)
Return on Tangible Assets Full definition →	(7,422.03%)	(1,862.07%)	0.00%	(241.91%)
Average Days of Receivables Full definition →	18.56	11.58	0.00	13.53
Free Cash Flow per Share Full definition →	(0.06)	(0.04)	—	(0.05)
Free Cash Flow Full definition →	(5.69)	(4.08)	—	(4.83)
Capital Expenditures Full definition →	(0.35)	0.64	—	(0.02)
Other line items
Cash ROIC Full definition →	(75.15%)	(56.08%)	0.00%	(51.69%)
Accounts Receivable Turnover Full definition →	15.40	32.85	0.00	26.02
Accounts Payable Turnover Full definition →	0.58	0.66	0.00	0.85
Inventory Turnover Full definition →	0.75	0.70	0.00	0.55
Average Days of Payables Full definition →	792.71	650.67	0.00	385.24
Days of Inventory on Hand Full definition →	313.56	330.78	0.00	403.65
Tax Rate Full definition →	0.00	0.00	—	0.00
Research and Development Expense of Revenue Full definition →	463.31%	403.77%	—	387.70%
Selling, General and Administrative Expense of Revenue Full definition →	481.47%	379.85%	—	390.42%
Share Based Compensation of Revenue Full definition →	225.52%	187.91%	—	141.32%
Operating CF/Net income Full definition →	0.61	0.67	—	0.75
Depreciation/Fixed assets Full definition →	0.11	0.15	0.00	0.19
Capex/Depreciation Full definition →	(1.58)	2.02	—	(0.05)
Revenue per Share Full definition →	0.01	0.01	—	0.01
Operating CF per Share Full definition →	(0.05)	(0.05)	—	(0.05)
Capex per Share Full definition →	0.00	0.01	—	0.00
Capex to Sales Full definition →	0.32	(0.55)	—	0.02

Show all line items

Columns are period end dates · fundamentals updated 5 Oct 2026

Stockrow Weekly